-
AI
Embracing AI technologies, we develop the AI algorithm platform for novel biomarker screening, supporting our innovative diagnostics, biopharma and biotherapy business. We also explore application of AI in the biopharma R&D system. -
AI + multi-omics platform
With multi-omics assay techniques, multi-omics-based machine learning algorithms and natural language processing, we seek to build an AI-enabled multi-omics platform to explore biomarkers and therapeutic targets that contributes to personalized treatment and early diagnosis, and develop a molecular diagnostics pipeline from discovery, proof of concept, product development to product registration. -
Fapon Digiwiser
Fapon Digiwiser develops an efficient biologic R&D platform, built on data powered by high performance computing and AI, for target discovery, candidate screening, protein and nucleic acid engineering, and safety prediction. By integrating diagnostics, therapeutics and research, it is committed to providing premium therapeutics, diagnostics and patient care to everyone.More
